Access Vascular
An operator at Access Vascular, Inc is responsible for assembling and producing high-quality medical devices within manufacturing, ensuring compliance with quality standards and maintaining a safe work environment.
Headquarters
Billerica, Massachusetts, United States
Company Size
11-50 employees
Founded
2015
Access Vascular develops novel hydrophilic biomaterial vascular access devices, including a midline catheter (HydroMID) and peripherally inserted central catheter (PICC). Their biomaterial is engineered to significantly reduce complications — data cited show up to 6x fewer complications with HydroMID and 99.99% less bacterial adhesion versus polyurethane in a blood-loop model. The company targets hospitals and infusion providers to improve patient outcomes and lower infection and complication rates across acute and home-care settings. Clinical evidence and material innovation are positioned as their core differentiators in transforming vascular access outcomes.
FDA Clears Access Vascular HydroMid® and HydroPICC® Catheters With Anti-Thrombogenic Indication
Oct 21, 2025
Vascular Access Device Market Size, Top Share And Regional Analysis by 2033
Jun 11, 2025
Pediatric Vascular Access Market Size & Growth Forecast to 2030
Nov 24, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Access Vascular.
5% above the average for this role
Global Vascular Access Device Market Size is growing at a CAGR of 6.40% by 2032, estimates DelveInsight
3 weeks ago